Cardiac tamponade, also known as pericardial tamponade, is when fluid in the pericardium (the sac around the heart) builds up, resulting in compression of the heart. Onset may be rapid or gradual. Symptoms typically include those of cardiogenic shock including shortness of breath, weakness, lightheadedness, and cough.
Cardiac Tamponade Market contains market size and forecasts of Cardiac Tamponade in Global, including the following market information:
- Global Cardiac Tamponade Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cardiac Tamponade market was valued at 4212.5 million in 2021 and is projected to reach US$ 5169.1 million by 2028, at a CAGR of 3.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
X-Ray Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cardiac Tamponade include Boston Scientific Corporation, Medtronic, Abbott, Hitachi, Ltd., Koninklijke Philips N.V., Siemens AG, Cardio Vascular Services, General Electric and Edwards Lifesciences Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cardiac Tamponade companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cardiac Tamponade Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cardiac Tamponade Market Segment Percentages, by Type, 2021 (%)
- X-Ray
- Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Coronary Angiography
- Electrocardiogram (EKG)
- Others.
Global Cardiac Tamponade Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cardiac Tamponade Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Clinics
- Cardiac Centers
- Academic Institutes
- Research Institutes
- Others
Global Cardiac Tamponade Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cardiac Tamponade Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Cardiac Tamponade revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Cardiac Tamponade revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Boston Scientific Corporation
- Medtronic
- Abbott
- Hitachi, Ltd.
- Koninklijke Philips N.V.
- Siemens AG
- Cardio Vascular Services
- General Electric
- Edwards Lifesciences Corporation
- Summit Medical Group
- Clinical Care Options, LLC.
- High Impact Incorporated
- Epic Medical Concepts & Innovations
Industry Market Size
